Oncology Research and Treatment

Article	Citations
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	26
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	26
PharmaNews	26
uGI: Biomaker-Cut-Offs in der Immunonkologie	25
Polypharmazie - Wechselwirkungen der BTKi	25
Front & Back Matter	21
PharmaNews	19
Front & Back Matter	18
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab	15
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer	14
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	14
Society Bulletins	13
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	10
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis	9
Society Bulletins	9
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	9
Career and Professional Development for Young Oncologists	9
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy	8
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice	8
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?	8
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem	7
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	7
OnkoImmun 21	7
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors	7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	7

PharmaNews	7
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study	7
Society Bulletins	6
Front & Back Matter	6
PharmaNews	6
DKK 2024: Acalabrutinib im Praxis-Check	6
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75	6
PharmaNews	6
Front & Back Matter	6
Front & Back Matter	6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine	6
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz	6
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer	6
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report	5
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany	5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology	5
PharmaNews	5
Erratum	5
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative	5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	5
Vorwort des DGHO-Vorstands	5
Society Bulletins	5
Capivasertib/Fulvestrant bei ER+/HER2– MBC	5
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	5
Epcoritamab: Indikationserweiterung für das FL	5
NSCLC: RWE-Daten zur Sequenztherapie	5
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	4
Therapiemanagement von Sacituzumab Govitecan	4
Durvalumab auch bei Hirnmetastasen vorteilhaft	4
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	4
PharmaNews	4
Society Bulletins	4
PharmaNews	4
Prelims	4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	4
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	3
Perspectives for Cancer Care and Research in Central and Eastern Europe	3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer	3
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation	3
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models	3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi	3
Risk and Prognosis of Subsequent Primary Gastric Cancer	3
Society Bulletins	3
Das inoperable NSCLC im Stadium III im Dialog	3
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report	3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac	3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	3
Management of Advanced Penile Cancer	3

Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	3
Guidelines of Onkopedia: What Is New?	2
Society Bulletins	2
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines	2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study	2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	2
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	2
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis	2
Society Bulletins	2
Front & Back Matter	2
Erweiterte Therapieoptionen bei EGFRm NSCLC	2
Society Bulletins	2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie	2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	2
Acknowledgement to Reviewers	2
Front & Back Matter	2
OnkoImmun 19	2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers	2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	2
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin	2
PharmaNews	2
Management of Patients Undergoing CAR-T Cell Therapy in Germany	2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich	2
Prelims	2
Recent Advances in Castleman Disease	2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey	2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy	2
PharmaNews	2
PharmaNews	2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy	2
Oncology in Europe	2
Society Bulletins	2
Nivolumab plus Ipilimumab beim metastasierten Melanom	2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines	2
Society Bulletins	2
Nintedanib und Docetaxel beim Adenokarzinom der Lunge	2
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study	2
Front & Back Matter	1
ALL - Blinatumomab verbesserte die Prognose für Kinder	1
Prognostic Significance of HER2 Positivity in Endometrium Cancer	1
Society Bulletins	1
Contents Vol. 47, 2024	1
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review	1
PharmaNews	1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis	1
Onkologische Patient*innen individuell behandeln und begleiten	1
PharmaNews	1
Society Bulletins	1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis	1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries	1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment	1
OnkoImmun 18	1
Front & Back Matter	1
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer	1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma	1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres	1
Society Bulletins	1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma	1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC	1
PharmaNews	1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast	1
Acknowledgement to Reviewers	1
Front & Back Matter	1
Prelims	1
PharmaNews	1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018	1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies	1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel	1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	1
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
Front & Back Matter	0
Effektive Therapieoption: Pegcetacoplan bei PNH	0
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort	0
Machine Learning-Based Prognostic Modeling of Seven Signatures Associated with Lysosomes for Predicting Prognosis and Immune Status in Clear Cell Renal Cell Carcinoma	0
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem-Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer Centers	0
Before-and-after Studies in Oncology: How Real Is the Real-World Evidence?	0

Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?	0
PharmaNews	0
PharmaNews	0
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report	0
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection	0
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer	0
Society Bulletins	0
PharmaNews	0
Abemaciclib beim eBC und mBC	0
The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)	0
TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma	0
Neu bei mCRPC: Talazoparib + Enzalutamid	0
Management of Advanced Germ Cell Tumors	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
PharmaNews	0
Society Bulletins	0
Front & Back Matter	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
Ibrutinib: signifikanter OS-Vorteil gegenüber FCR	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0
Melflufen: Therapieoptionen beim Multiplen Myelom	0
PharmaNews	0
Society Bulletins	0
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Pat	0
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome	0
Zulassungserweiterung Yescarta beim r/r FL	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0
Momelotinib bei Myelofibrose und Anämie	0
Vorwort des DGHO-Vorstandes	0
BTKi: die Entwicklung geht weiter	0
Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy	0
Treatment Navigation in Breast Cancer Management: Process Cost Analysis Based on German Case Studies	0
Paraneoplastic Papillitis as a Precursor to Colon Carcinoma: A Case of Unexpected Vision Loss Leading to Early Cancer Detection	0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy	0
Molecular Tissue Profiling in a Clinically Selected Pancreatic Cancer Cohort	0
Effectiveness and Safety of Combining Transarterial Chemoembolization with Tyrosine Kinase and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Meta-Analysis	0
Society Bulletins	0
Prelims	0
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database	0
Prelims	0
Front & Back Matter	0
Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study	0
Osimertinib: Hohe Wirksamkeit im Zentralnervensystem	0
Frontline pembrolizumab or methotrexate in elderly, frail, or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-HNSCC) – results of the randomi	0
Safety of Surgery within 24 h following Colonoscopy for Colorectal Cancer: A Retrospective Propensity Scores Matched Analysis	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
Society Bulletins	0
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism	0
Managing Antithrombotic Treatment in Patients with Immune Thrombocytopenia	0
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases	0
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
The Path to Clinical Implementation of DPYD Pharmacogenetic Testing: Long-Term Experience from an External Quality Assessment Provider and a University Testing Center	0
Treatment Satisfaction and Treatment Wishes of Patients with Chronic Cancer-Related Pain	0
Albert Schweitzer, Chronic Myeloid Leukemia, and War	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
PharmaNews	0
PharmaNews	0
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland	0
PharmaNews	0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
Five-Fraction Stereotactic Radiotherapy for Brain Metastases: A Single-Institution Experience on Different Dose Schedules	0
Prelims	0
Society Bulletins	0
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study	0
Atezolizumab beim operablen NSCLC	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
PharmaNews	0
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis	0
r/r DLBCL: Heilungschance mit Axi-Cel	0
A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors	0
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie	0
Front & Back Matter	0
Society Bulletins	0
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network	0
Supportive Therapie bei Krebs: AGSMO Jahreskongress 2025, 24. Mai 2025, Berlin und online – Abstracts	0
Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic	0
PharmaNews	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0
The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvan	0
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma	0
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review	0
PharmaNews	0
A Real-World Evaluation of Brain Imaging in Patients with Advanced Non-Small Cell Lung Cancer: Insights from a German Claims Data Analysis	0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:	0
Highlights from ESMO 2024 as a Young Head and Neck Oncologist	0
PharmaNews	0
Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis	0
Society Bulletins	0
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems	0